ZUH:CA:TSX-BMO Equal Weight US Health Care (CAD Hedged) (CAD)

ETF | Sector Equity |

Last Closing

CAD 67.57

Change

+0.29 (+0.43)%

Market Cap

CAD 0.23B

Volume

1.60K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-08 )

Largest Industry Peers for Sector Equity

Symbol Name Price(Change) Market Cap
TEC:CA TD Global Technology Leaders I..

+0.06 (+0.13%)

CAD 3.43B
ZWU:CA BMO Covered Call Utilities ETF

+0.04 (+0.33%)

CAD 1.81B
XIT:CA iShares S&P/TSX Capped Informa..

+1.40 (+2.08%)

CAD 0.78B
HTA:CA Harvest Tech Achievers Growth ..

-0.02 (-0.11%)

CAD 0.68B
TXF:CA First Asset Tech Giants Covere..

-0.07 (-0.33%)

CAD 0.67B
XHC:CA iShares Global Healthcare (CAD..

+0.41 (+0.62%)

CAD 0.54B
ZUT:CA BMO Equal Weight Utilities Ind..

-0.27 (-1.22%)

CAD 0.51B
XUT:CA iShares S&P/TSX Capped Utiliti..

-0.13 (-0.46%)

CAD 0.37B
CWW:CA iShares Global Water Common Cl..

-0.29 (-0.51%)

CAD 0.31B
COW:CA iShares Global Agriculture Com..

N/A

CAD 0.27B

ETFs Containing ZUH:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Sector Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 2.83% 94% A 84% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 2.83% 94% A 84% B
Trailing 12 Months  
Capital Gain -3.49% 20% F 16% F
Dividend Return 0.70% 25% F 7% C-
Total Return -2.79% 11% F 14% F
Trailing 5 Years  
Capital Gain 10.28% 37% F 48% F
Dividend Return 2.71% 21% F 5% F
Total Return 12.99% 17% F 31% F
Average Annual (5 Year Horizon)  
Capital Gain 3.84% 34% F 47% F
Dividend Return 4.24% 23% F 42% F
Total Return 0.40% 29% F 27% F
Risk Return Profile  
Volatility (Standard Deviation) 16.02% 63% D 53% F
Risk Adjusted Return 26.49% 20% F 41% F
Market Capitalization 0.23B 65% D 48% F

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.